Abstract
Late-life depression (LLD) is a major source of global morbidity and mortality, influenced by multiple risk factors. Yet, a major challenge is to quantify the degree of resilience or vulnerability to LLD at the individual level, which could offer neurobiological insight and ultimately inform future interventions and treatment. Here, applying a non-parametric regression model to the UK Biobank data (N=1,988), we quantified brain-based resilience and vulnerability to LLD and tested whether risk factors could explain individual differences in the estimated magnitude of such neural resilience and vulnerability. Our results show that social isolation was positively associated with the median magnitude of neural vulnerability whereas material deprivation was negatively associated with the greatest neural resilience (top 10 percentile). These results together highlight the importance of social interaction and access to sufficient resources and services in diminishing neural vulnerability and promoting neural resilience to LLD, respectively. Our findings therefore provide insights into preventive strategies for LLD, and thus are of importance for policy makers as well as the broader society.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This research was supported by the NIH (1 R34 NS118618-01) and the McDonnell Center for Systems Neuroscience.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
Data used in this study are publicly available at UK Biobank (https://www.ukbiobank.ac.uk/). Data access was obtained under UK Biobank application ID 47267.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Competing Interest Statement: No competing interests.
Data Availability
Data used in this study are publicly available at UK Biobank (https://www.ukbiobank.ac.uk/). All data produced in the present study are available upon reasonable request to the authors.
